PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) ...
Inspira Technologies (IINN) announced positive results from the clinical study of its AI-powered HYLA blood sensor. The HYLA achieved 96% ...
13don MSN
Inspira Technologies' HYLA blood sensor achieves 96% accuracy in clinical study, paving the way for FDA submission by 2025.
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
Carbon monoxide can be a silent, odorless and invisible killer, but it can still be detected. Protect your family with these ...
Servomex is helping chemical manufacturers reduce their environmental impact and enhance safety and productivity by ...
The value of pressure sensing in medical equipment was highlighted during the COVID-19 pandemic. Discover how new tools are revolutionizing the field.
Significant progress in HYLA blood sensor and INSPIRA ART core technologies RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback